Zacks.com introduces its $100K Challenge 2007 top player interviews, which feature insights from the leaders of the Zacks Simulator game. This year the Simulator’s $100K Challenge allows investors to prove their stock picking abilities by competing directly against other players for a possible $100,000 contract with Zacks.
Jim Treyens (aka Seatac) describes himself as diversified and eclectic when it comes to trading stocks. This Simulator player will also employ aggressive strategies if needed. "Some of my stocks should have potential for explosive growth, kind of like a venture capital fund that knows it won't make money on eight of ten investments but can make a whole lot of money on one or two," mentioned Jim.
His current Zacks $100K Challenge stocks include Natus Medical Inc. (Nasdaq: BABY), Dendreon Corp. (Nasdaq: DNDN), Gilead Sciences Inc. (Nasdaq: GILD), ZymoGenetics, Inc. (Nasdaq: ZGEN) and Seattle Genetics Inc. (Nasdaq: SGEN). Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=2518.
Highlights from the April 12 interview include:
How does he know what to buy?
“I look for companies that either have the potential for explosive growth, or sustained growth based on product, market, and quality management,” replied Jim.
His current Zacks $100K Challenge stocks include Natus Medical Inc. (Nasdaq: BABY), Dendreon Corp. (Nasdaq: DNDN), Gilead Sciences Inc. (Nasdaq: GILD), ZymoGenetics, Inc. (Nasdaq: ZGEN) and Seattle Genetics Inc. (Nasdaq: SGEN). Click here to check out this competitor’s entire portfolio: http://at.zacks.com/?id=3314.
How about selling?
To maintain diversification, this investor will sell if a stock has grown to represent more than 20% of his portfolio. He will execute a sell order when he sees a good replacement for a holding that has disappointed over a period of time.
Check out the complete interview and learn more about the Simulator at: http://at.zacks.com/?id=2518.
The $100K Challenge is On! Do You Have What it Takes?
Sign up now for the Zacks $100K Challenge. It's free. It's fun. It's the place to show your investing prowess. The best stock picker will be rewarded with a $100,000 contract with Zacks. Learn more at http://at.zacks.com/?id=2520.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=2521
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
(a) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
